Triple
T16851891
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Truvada |
E409694
|
entity |
| Predicate | FDAApprovalIndication |
P113308
|
FINISHED |
| Object | treatment of HIV-1 infection in combination with other antiretrovirals |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: treatment of HIV-1 infection in combination with other antiretrovirals | Statement: [Truvada, FDAApprovalIndication, treatment of HIV-1 infection in combination with other antiretrovirals]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: FDAApprovalIndication Context triple: [Truvada, FDAApprovalIndication, treatment of HIV-1 infection in combination with other antiretrovirals]
-
A.
FDAApprovalType
Indicates the specific regulatory pathway or category under which a product has been approved by the U.S. Food and Drug Administration.
-
B.
treatmentIndication
chosen
Indicates that a treatment is intended to address, alleviate, or prevent a particular condition, symptom, or medical indication.
-
C.
isFirstDrugApprovedFor
Indicates that a drug is the earliest or original medication approved for treating a particular condition, disease, or indication.
-
D.
hasOrphanDrugDesignation
Indicates that a drug or therapeutic product has been granted orphan drug designation by a regulatory authority, recognizing it as intended for the treatment of a rare disease or condition.
-
E.
FDAApplicationNumber
Indicates the unique application identifier assigned by the U.S. Food and Drug Administration (FDA) to a specific product submission or regulatory filing.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d88395e6c88190b22730f335107c14 |
completed | April 10, 2026, 4:59 a.m. |
| NER | Named-entity recognition | batch_69e3b379b8fc81908d8bc9950c7f8bad |
completed | April 18, 2026, 4:38 p.m. |
| PD | Predicate disambiguation | batch_69e32b8cbb048190878a259cc5be960e |
completed | April 18, 2026, 6:58 a.m. |
Created at: April 10, 2026, 5:24 a.m.